CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis

Abstract

BackgroundThe impact of sarcopenia on the outcome of gastrointestinal (GI) oncological patients is still controversial. We aim to discuss the prevalence of sarcopenia and its relation to the oncological outcome.MethodsEmbase, Medline, PubMed, and the Cochrane library were systematically searched for related keywords. Studies using CT to assess sarcopenia and evaluate its relationship with the outcome of GI oncological patients were included. Long-term outcomes, including overall survival and disease-free survival, were compared by hazard ratios (HRs) with 95% confidence intervals (CIs). Short-term outcomes, including total complications and major complications (Clavien-Dindo ≥IIIa) after curable surgery, were compared by the risk ratio (RR) and 95% CI.ResultsA total of 70 studies including 21,875 patients were included in our study. The median incidence of sarcopenia was 34.7% (range from 2.1 to 83.3%). A total of 88.4% of studies used skeletal muscle index (SMI) in the third lumbar level on CT to define sarcopenia, and a total of 19 cut-offs were used to define sarcopenia. An increasing trend was found in the prevalence of sarcopenia when the cut-off of SMI increased (β = 0.22, 95% CI = 0.12–0.33, p < 0.001). The preoperative incidence of sarcopenia was associated both with an increased risk of overall mortality (HR = 1.602, 95% CI = 1.369–1.873, P < 0.001) and with disease-free mortality (HR = 1.461, 95% CI = 1.297–1.646, P < 0.001). Moreover, preoperative sarcopenia was a risk factor for both total complications (RR = 1.188, 95% CI = 1.083–1.303, P < 0.001) and major complications (RR = 1.228, 95% CI = 1.042–1.448, P = 0.014).ConclusionThe prevalence of sarcopenia depends mostly on the diagnostic cut-off points of different criteria. Preoperative sarcopenia is a risk factor for both long-term and short-term outcomes.

Sarcopenia as A Predictor of Mortality Among the Critically Ill in an Intensive Care Unit: A Systematic Review and Meta-Analysis

“…Our subgroup results found that when considering the reasons for admission, critically ill patients with sarcopenia have an increased risk of mortality, profoundly con rming that sarcopenia could be a prognostic factor in critical illness. Our ndings are in line with previous research, which has found that older adults with sarcopenia are at increased risk of mortality in other settings, such as the community 36 , nursing homes 43 , or in an oncology setting [44][45][46] . According to published studies, the main reason explaining the relationship between sarcopenia and mortality is lower muscle mass, which has been con rmed as a strong predictor for an increased risk of death 31,47 .…”

Sarcopenia: Unraveling the network

“…Diminished muscle mass and strength defining sarcopenia have been increasingly reported as important components of a network of elements influencing perioperative outcomes in cancer surgery. Diagnosis of sarcopenia, as reasonably expected, was associated with increased postoperative complications, length of hospital stay, and mortality in various clinical settings 2 …”

Sarcopenia and adverse health‐related outcomes: An umbrella review of meta‐analyses of observational studies

“…Then, we chose the newest meta‐analysis with the largest number of studies. Finally, 54 health‐related outcomes extracted from 30 meta‐analyses 10,22‐50 were reported in this umbrella review. These 54 outcomes were mainly about prognostic outcomes of tumor, postoperative outcomes, age‐related outcomes, metabolic outcomes, and other outcomes.…”